Literature DB >> 1494170

Action myoclonus after cerebral hypoxia: treatment with clonazepam.

R Rustom1, R A Fisken.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494170      PMCID: PMC1293770          DOI: 10.1177/014107689208501218

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  7 in total

1.  The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy.

Authors:  J W LANCE; R D ADAMS
Journal:  Brain       Date:  1963-03       Impact factor: 13.501

2.  Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.

Authors:  D Chadwick; M Hallett; P Jenner; C D Marsden
Journal:  Adv Neurol       Date:  1986

3.  Ballistic movement overflow myoclonus a form of essential myoclonus.

Authors:  M Hallett; D Chadwick; C D Marsden
Journal:  Brain       Date:  1977-06       Impact factor: 13.501

4.  Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus.

Authors:  M Hallett; D Chadwick; J Adam; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-03       Impact factor: 10.154

5.  Manipulation of brain serotonin in the treatment of myoclonus.

Authors:  D Chadwick; P Jenner; R Harris; E H Reynolds; C D Marsden
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

6.  Cortical reflex myoclonus.

Authors:  M Hallett; D Chadwick; C D Marsden
Journal:  Neurology       Date:  1979-08       Impact factor: 9.910

7.  Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.

Authors:  D Chadwick; M Hallett; R Harris; P Jenner; E H Reynolds; C D Marsden
Journal:  Brain       Date:  1977-09       Impact factor: 13.501

  7 in total
  1 in total

1.  Squint--an etiological marker in microcephaly.

Authors:  M A Phadke; S M Bhate; P S Gambhir; S L Kate
Journal:  J R Soc Med       Date:  1994-01       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.